Global PD-1 and PD-L1 Inhibitors Sales Market Report 2023

Report ID: 889466 | Published Date: Mar 2026 | No. of Page: 140 | Base Year: 2025 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 PD-1 and PD-L1 Inhibitors Market Overview
    1.1 PD-1 and PD-L1 Inhibitors Product Scope
    1.2 PD-1 and PD-L1 Inhibitors Segment by Type
        1.2.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2016 & 2021 & 2027)
        1.2.2 Humanized IgG1(Immunoglobulin 1)
        1.2.3 Humanized IgG4(Immunoglobulin 5)
        1.2.4 Cytokine
    1.3 PD-1 and PD-L1 Inhibitors Segment by Application
        1.3.1 Global PD-1 and PD-L1 Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Oral
        1.3.3 Subcutaneous Injection
    1.4 PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts (2016-2027)
        1.4.1 Global PD-1 and PD-L1 Inhibitors Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global PD-1 and PD-L1 Inhibitors Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global PD-1 and PD-L1 Inhibitors Price Trends (2016-2027)

2 PD-1 and PD-L1 Inhibitors Estimates and Forecasts by Region
    2.1 Global PD-1 and PD-L1 Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
        2.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)
    2.3 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
        2.4.2 Europe PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
        2.4.3 China PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
        2.4.4 Japan PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
        2.4.6 India PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
3 Global PD-1 and PD-L1 Inhibitors Competition Landscape by Players
    3.1 Global Top PD-1 and PD-L1 Inhibitors Players by Sales (2016-2021)
    3.2 Global Top PD-1 and PD-L1 Inhibitors Players by Revenue (2016-2021)
    3.3 Global PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2020)
    3.4 Global PD-1 and PD-L1 Inhibitors Average Price by Company (2016-2021)
    3.5 Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global PD-1 and PD-L1 Inhibitors Market Size by Type
    4.1 Global PD-1 and PD-L1 Inhibitors Historic Market Review by Type (2016-2021)
        4.1.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
        4.1.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)
        4.1.3 Global PD-1 and PD-L1 Inhibitors Price by Type (2016-2021)
    4.2 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2022-2027)
        4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2022-2027)
        4.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Type (2022-2027)
5 Global PD-1 and PD-L1 Inhibitors Market Size by Application
    5.1 Global PD-1 and PD-L1 Inhibitors Historic Market Review by Application (2016-2021)
        5.1.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
        5.1.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2016-2021)
        5.1.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2016-2021)
    5.2 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2022-2027)
        5.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2022-2027)
        5.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Application (2022-2027)

6 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures
    6.1 North America PD-1 and PD-L1 Inhibitors Sales by Company
        6.1.1 North America PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
        6.1.2 North America PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
    6.2 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
        6.2.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
        6.2.2 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
    6.3 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
        6.3.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2016-2021)
        6.3.2 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2022-2027)

7 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures
    7.1 Europe PD-1 and PD-L1 Inhibitors Sales by Company
        7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
        7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
    7.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
        7.2.1 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
        7.2.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
    7.3 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
        7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China PD-1 and PD-L1 Inhibitors Market Facts & Figures
    8.1 China PD-1 and PD-L1 Inhibitors Sales by Company
        8.1.1 China PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
        8.1.2 China PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
    8.2 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
        8.2.1 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
        8.2.2 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
    8.3 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
        8.3.1 China 313 Sales Breakdown by Application (2016-2021)
        8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan PD-1 and PD-L1 Inhibitors Market Facts & Figures
    9.1 Japan PD-1 and PD-L1 Inhibitors Sales by Company
        9.1.1 Japan PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
        9.1.2 Japan PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
    9.2 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
        9.2.1 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
        9.2.2 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
    9.3 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia PD-1 and PD-L1 Inhibitors Market Facts & Figures
    10.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Company
        10.1.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
        10.1.2 Southeast Asia PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
    10.2 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
        10.2.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
        10.3.1 Southeast Asia Tons Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia Tons Sales Breakdown by Application (2022-2027)

11 India PD-1 and PD-L1 Inhibitors Market Facts & Figures
    11.1 India PD-1 and PD-L1 Inhibitors Sales by Company
        11.1.1 India PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
        11.1.2 India PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
    11.2 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
        11.2.1 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
        11.2.2 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
    11.3 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
        11.3.1 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2016-2021)
        11.3.2 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in PD-1 and PD-L1 Inhibitors Business
    12.1 Merck
        12.1.1 Merck Corporation Information
        12.1.2 Merck Business Overview
        12.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Merck PD-1 and PD-L1 Inhibitors Products Offered
        12.1.5 Merck Recent Development
    12.2 Novartis
        12.2.1 Novartis Corporation Information
        12.2.2 Novartis Business Overview
        12.2.3 Novartis PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Novartis PD-1 and PD-L1 Inhibitors Products Offered
        12.2.5 Novartis Recent Development
    12.3 Bristol-Myers Squibb
        12.3.1 Bristol-Myers Squibb Corporation Information
        12.3.2 Bristol-Myers Squibb Business Overview
        12.3.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Products Offered
        12.3.5 Bristol-Myers Squibb Recent Development
    12.4 GlaxoSmithKline
        12.4.1 GlaxoSmithKline Corporation Information
        12.4.2 GlaxoSmithKline Business Overview
        12.4.3 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Products Offered
        12.4.5 GlaxoSmithKline Recent Development
    12.5 Regeneron Pharmaceuticals
        12.5.1 Regeneron Pharmaceuticals Corporation Information
        12.5.2 Regeneron Pharmaceuticals Business Overview
        12.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Products Offered
        12.5.5 Regeneron Pharmaceuticals Recent Development
    12.6 Eli Lilly and Company
        12.6.1 Eli Lilly and Company Corporation Information
        12.6.2 Eli Lilly and Company Business Overview
        12.6.3 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Products Offered
        12.6.5 Eli Lilly and Company Recent Development
    12.7 Roche Genetech
        12.7.1 Roche Genetech Corporation Information
        12.7.2 Roche Genetech Business Overview
        12.7.3 Roche Genetech PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Roche Genetech PD-1 and PD-L1 Inhibitors Products Offered
        12.7.5 Roche Genetech Recent Development
    12.8 AstraZeneca
        12.8.1 AstraZeneca Corporation Information
        12.8.2 AstraZeneca Business Overview
        12.8.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 AstraZeneca PD-1 and PD-L1 Inhibitors Products Offered
        12.8.5 AstraZeneca Recent Development
    12.9 Jiangsu HengRui Medicine Co., Ltd.
        12.9.1 Jiangsu HengRui Medicine Co., Ltd. Corporation Information
        12.9.2 Jiangsu HengRui Medicine Co., Ltd. Business Overview
        12.9.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Products Offered
        12.9.5 Jiangsu HengRui Medicine Co., Ltd. Recent Development
    12.10 Curis Inc.
        12.10.1 Curis Inc. Corporation Information
        12.10.2 Curis Inc. Business Overview
        12.10.3 Curis Inc. PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Curis Inc. PD-1 and PD-L1 Inhibitors Products Offered
        12.10.5 Curis Inc. Recent Development
    12.11 Aurigene
        12.11.1 Aurigene Corporation Information
        12.11.2 Aurigene Business Overview
        12.11.3 Aurigene PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Aurigene PD-1 and PD-L1 Inhibitors Products Offered
        12.11.5 Aurigene Recent Development

13 PD-1 and PD-L1 Inhibitors Manufacturing Cost Analysis
    13.1 PD-1 and PD-L1 Inhibitors Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
    13.4 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 PD-1 and PD-L1 Inhibitors Distributors List
    14.3 PD-1 and PD-L1 Inhibitors Customers

15 Market Dynamics
    15.1 PD-1 and PD-L1 Inhibitors Market Trends
    15.2 PD-1 and PD-L1 Inhibitors Drivers
    15.3 PD-1 and PD-L1 Inhibitors Market Challenges
    15.4 PD-1 and PD-L1 Inhibitors Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global PD-1 and PD-L1 Inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global PD-1 and PD-L1 Inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global PD-1 and PD-L1 Inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Region (2016-2021)
    Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
    Table 6. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global PD-1 and PD-L1 Inhibitors Revenue Share by Region (2016-2021)
    Table 8. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Forecast by Region (2022-2027)
    Table 9. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global PD-1 and PD-L1 Inhibitors Revenue Share Forecast by Region (2022-2027)
    Table 12. Global PD-1 and PD-L1 Inhibitors Sales (Tons) of Key Companies (2016-2021)
    Table 13. Global PD-1 and PD-L1 Inhibitors Sales Share by Company (2016-2021)
    Table 14. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global PD-1 and PD-L1 Inhibitors Revenue Share by Company (2016-2021)
    Table 16. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2020)
    Table 17. Global PD-1 and PD-L1 Inhibitors Average Price (US$/Kg) of Key Company (2016-2021)
    Table 18. Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites and Area Served
    Table 19. Manufacturers PD-1 and PD-L1 Inhibitors Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Type (2016-2021)
    Table 22. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2016-2021)
    Table 23. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global PD-1 and PD-L1 Inhibitors Price (US$/Kg) by Type (2016-2021)
    Table 25. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2022-2027)
    Table 26. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2022-2027)
    Table 28. Global PD-1 and PD-L1 Inhibitors Price (US$/Kg) by Type (2022-2027)
    Table 29. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Application (2016-2021) 
    Table 30. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2016-2021)
    Table 31. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global PD-1 and PD-L1 Inhibitors Price (US$/Kg) by Application (2016-2021)
    Table 33. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Application (2022-2027)
    Table 34. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2022-2027)
    Table 35. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2022-2027)
    Table 37. Global PD-1 and PD-L1 Inhibitors Price (US$/Kg) by Application (2022-2027)
    Table 38. North America PD-1 and PD-L1 Inhibitors Sales (Tons) by Company (2016-2021)
    Table 39. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
    Table 40. North America PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
    Table 42. North America PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (Tons)
    Table 43. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
    Table 44. North America PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (Tons)
    Table 45. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
    Table 46. North America PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (Tons)
    Table 47. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
    Table 48. North America PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (Tons)
    Table 49. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
    Table 50. Europe PD-1 and PD-L1 Inhibitors Sales (Tons) by Company (2016-2021)
    Table 51. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
    Table 52. Europe PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
    Table 54. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (Tons)
    Table 55. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
    Table 56. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (Tons)
    Table 57. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
    Table 58. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (Tons)
    Table 59. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
    Table 60. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (Tons)
    Table 61. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
    Table 62. China PD-1 and PD-L1 Inhibitors Sales (Tons) by Company (2016-2021)
    Table 63. China PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
    Table 64. China PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
    Table 66. China PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (Tons)
    Table 67. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
    Table 68. China PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (Tons)
    Table 69. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
    Table 70. China PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (Tons)
    Table 71. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
    Table 72. China PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (Tons)
    Table 73. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
    Table 74. Japan PD-1 and PD-L1 Inhibitors Sales (Tons) by Company (2016-2021)
    Table 75. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
    Table 76. Japan PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
    Table 78. Japan PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (Tons)
    Table 79. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
    Table 80. Japan PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (Tons)
    Table 81. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
    Table 82. Japan PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (Tons)
    Table 83. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
    Table 84. Japan PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (Tons)
    Table 85. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (Tons) by Company (2016-2021)
    Table 87. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (Tons)
    Table 91. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (Tons)
    Table 93. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (Tons)
    Table 95. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (Tons)
    Table 97. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
    Table 98. India PD-1 and PD-L1 Inhibitors Sales (Tons) by Company (2016-2021)
    Table 99. India PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
    Table 100. India PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
    Table 102. India PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (Tons)
    Table 103. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
    Table 104. India PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (Tons)
    Table 105. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
    Table 106. India PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (Tons)
    Table 107. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
    Table 108. India PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (Tons)
    Table 109. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
    Table 110. Merck Corporation Information
    Table 111. Merck Description and Business Overview
    Table 112. Merck PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 113. Merck PD-1 and PD-L1 Inhibitors Product
    Table 114. Merck Recent Development
    Table 115. Novartis Corporation Information
    Table 116. Novartis Description and Business Overview
    Table 117. Novartis PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 118. Novartis PD-1 and PD-L1 Inhibitors Product
    Table 119. Novartis Recent Development
    Table 120. Bristol-Myers Squibb Corporation Information
    Table 121. Bristol-Myers Squibb Description and Business Overview
    Table 122. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 123. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product
    Table 124. Bristol-Myers Squibb Recent Development
    Table 125. GlaxoSmithKline Corporation Information
    Table 126. GlaxoSmithKline Description and Business Overview
    Table 127. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 128. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Product
    Table 129. GlaxoSmithKline Recent Development
    Table 130. Regeneron Pharmaceuticals Corporation Information
    Table 131. Regeneron Pharmaceuticals Description and Business Overview
    Table 132. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 133. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Product
    Table 134. Regeneron Pharmaceuticals Recent Development
    Table 135. Eli Lilly and Company Corporation Information
    Table 136. Eli Lilly and Company Description and Business Overview
    Table 137. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 138. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Product
    Table 139. Eli Lilly and Company Recent Development
    Table 140. Roche Genetech Corporation Information
    Table 141. Roche Genetech Description and Business Overview
    Table 142. Roche Genetech PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 143. Roche Genetech PD-1 and PD-L1 Inhibitors Product
    Table 144. Roche Genetech Recent Development
    Table 145. AstraZeneca Corporation Information
    Table 146. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 147. AstraZeneca Description and Business Overview
    Table 148. AstraZeneca PD-1 and PD-L1 Inhibitors Product
    Table 149. AstraZeneca Recent Development
    Table 150. Jiangsu HengRui Medicine Co., Ltd. Corporation Information
    Table 151. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 152. Jiangsu HengRui Medicine Co., Ltd. Description and Business Overview
    Table 153. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Product
    Table 154. Jiangsu HengRui Medicine Co., Ltd. Recent Development
    Table 155. Curis Inc. Corporation Information
    Table 156. Curis Inc. Description and Business Overview
    Table 157. Curis Inc. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 158. Curis Inc. PD-1 and PD-L1 Inhibitors Product
    Table 159. Curis Inc. Recent Development
    Table 160. Aurigene Corporation Information
    Table 161. Aurigene Description and Business Overview
    Table 162. Aurigene PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2016-2021)
    Table 163. Aurigene PD-1 and PD-L1 Inhibitors Product
    Table 164. Aurigene Recent Development
    Table 165. Production Base and Market Concentration Rate of Raw Material
    Table 166. Key Suppliers of Raw Materials
    Table 167. PD-1 and PD-L1 Inhibitors Distributors List
    Table 168. PD-1 and PD-L1 Inhibitors Customers List
    Table 169. PD-1 and PD-L1 Inhibitors Market Trends
    Table 170. PD-1 and PD-L1 Inhibitors Market Drivers
    Table 171. PD-1 and PD-L1 Inhibitors Market Challenges
    Table 172. PD-1 and PD-L1 Inhibitors Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. PD-1 and PD-L1 Inhibitors Product Picture
    Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2021 & 2027
    Figure 6. Oral Examples
    Figure 7. Subcutaneous Injection Examples
    Figure 8. Global PD-1 and PD-L1 Inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Growth Rate (2016-2027)
    Figure 11. Global PD-1 and PD-L1 Inhibitors Price Trends Growth Rate (2016-2027) (US$/Kg)
    Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America PD-1 and PD-L1 Inhibitors Sales (Tons) Growth Rate (2016-2027)
    Figure 16. Europe PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China PD-1 and PD-L1 Inhibitors Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest PD-1 and PD-L1 Inhibitors Players Market Share by Revenue in PD-1 and PD-L1 Inhibitors: 2016 & 2020
    Figure 27. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2016-2021)
    Figure 29. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2016-2021)
    Figure 31. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
    Figure 33. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
    Figure 34. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
    Figure 35. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
    Figure 36. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
    Figure 37. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
    Figure 38. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
    Figure 39. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
    Figure 40. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
    Figure 41. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
    Figure 42. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
    Figure 43. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors 
    Figure 46. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
    Figure 47. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation 
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Novartis
Bristol-Myers Squibb
GlaxoSmithKline
Regeneron Pharmaceuticals
Eli Lilly and Company
Roche Genetech
AstraZeneca
Jiangsu HengRui Medicine Co., Ltd.
Curis Inc.
Aurigene
Frequently Asked Questions
PD-1 and PD-L1 Inhibitors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PD-1 and PD-L1 Inhibitors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PD-1 and PD-L1 Inhibitors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Photon Chip

The global Photon Chip market is segmented by company, region (country), by Type, and by Applicat ... Read More